Literature DB >> 25562198

ExcellmiRDB for translational genomics: a curated online resource for extracellular microRNAs.

Jitendra Kumar Barupal1, Ashok Kumar Saini, Tara Chand, Arun Meena, Surendra Beniwal, Jetha Ram Suthar, Narendra Meena, Sumita Kachhwaha, Shanker Lal Kothari.   

Abstract

A large number of studies have suggested extracellular microRNAs (microRNAs in biofluids) as potential noninvasive biomarkers for pathophysiological conditions such as cancer. However, reported differentially expressed signatures of extracellular miRNAs in diseases are not uniformly consistent among studies. Here, we present "ExcellmiRDB", a curated online database that provides integrated information about miRNAs levels in biofluids in a user-friendly way. Although many miRNA databases, including disease-oriented databases, have been launched before, the ExcellmiRDB is so far the only one specialized for storing curated data on miRNA levels in biofluid samples. At present, ExcellmiRDB has 2773 disease-extracellular miRNAs and 1108 biofluid-extracellular miRNAs relationships curated from 108 articles selected from more than 600 surveyed PubMed abstracts. Information about 992 miRNAs, 82 diseases, 21 biofluids, 8 species, 63 normalization reference genes, 5 techniques, 14 GEO profiles accession numbers, 7 human ethnic groups, and 18 compared clinical biomarkers have been provided in the database. A user can query ExcellmiRDB by selecting a disease or a miRNA or a biofluid. Additionally, the database provides two online network graphs to visualize and interact with the content of the database. The first network shows disease-extracellular miRNAs relationships, along with expression patterns and number of articles for a relationship. The second network visualizes biofluid-extracellular miRNAs relationships showing miRNAs spectrum across different types of biofluids. In conclusion, ExcellmiRDB is a new innovative resource for both academic and industrial researchers in translational omics who are developing miRNA biomarkers for noninvasive diagnostic or prognostic technologies. ExcellmiRDB is publicly available on www.excellmirdb.brfjaisalmer.com/.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25562198     DOI: 10.1089/omi.2014.0106

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  8 in total

1.  MicroRNA-196a2 Biomarker and Targetome Network Analysis in Solid Tumors.

Authors:  Eman A Toraih; Manal S Fawzy; Eman A Mohammed; Mohammad H Hussein; Mohamad M El-Labban
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

2.  HMDD v3.0: a database for experimentally supported human microRNA-disease associations.

Authors:  Zhou Huang; Jiangcheng Shi; Yuanxu Gao; Chunmei Cui; Shan Zhang; Jianwei Li; Yuan Zhou; Qinghua Cui
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

3.  miRNATissueAtlas2: an update to the human miRNA tissue atlas.

Authors:  Andreas Keller; Laura Gröger; Thomas Tschernig; Jeffrey Solomon; Omar Laham; Nicholas Schaum; Viktoria Wagner; Fabian Kern; Georges Pierre Schmartz; Yongping Li; Adam Borcherding; Carola Meier; Tony Wyss-Coray; Eckart Meese; Tobias Fehlmann; Nicole Ludwig
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

Review 4.  The Regulatory Roles of Non-coding RNAs in Angiogenesis and Neovascularization From an Epigenetic Perspective.

Authors:  Itzel Alejandra Hernández-Romero; Lissania Guerra-Calderas; Marisol Salgado-Albarrán; Tatiana Maldonado-Huerta; Ernesto Soto-Reyes
Journal:  Front Oncol       Date:  2019-10-24       Impact factor: 6.244

5.  Application of microRNA Database Mining in Biomarker Discovery and Identification of Therapeutic Targets for Complex Disease.

Authors:  Jennifer L Major; Rushita A Bagchi; Julie Pires da Silva
Journal:  Methods Protoc       Date:  2020-12-30

Review 6.  MicroRNA let-7 and viral infections: focus on mechanisms of action.

Authors:  Arash Letafati; Sajad Najafi; Mehran Mottahedi; Mohammad Karimzadeh; Ali Shahini; Setareh Garousi; Mohammad Abbasi-Kolli; Javid Sadri Nahand; Seyed Saeed Tamehri Zadeh; Michael R Hamblin; Neda Rahimian; Mohammad Taghizadieh; Hamed Mirzaei
Journal:  Cell Mol Biol Lett       Date:  2022-02-14       Impact factor: 5.787

Review 7.  miRNA therapeutics in precision oncology: a natural premium to nurture.

Authors:  Chakresh Kumar Jain; Poornima Srivastava; Amit Kumar Pandey; Nisha Singh; R Suresh Kumar
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

8.  miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database.

Authors:  Chih-Hung Chou; Nai-Wen Chang; Sirjana Shrestha; Sheng-Da Hsu; Yu-Ling Lin; Wei-Hsiang Lee; Chi-Dung Yang; Hsiao-Chin Hong; Ting-Yen Wei; Siang-Jyun Tu; Tzi-Ren Tsai; Shu-Yi Ho; Ting-Yan Jian; Hsin-Yi Wu; Pin-Rong Chen; Nai-Chieh Lin; Hsin-Tzu Huang; Tzu-Ling Yang; Chung-Yuan Pai; Chun-San Tai; Wen-Liang Chen; Chia-Yen Huang; Chun-Chi Liu; Shun-Long Weng; Kuang-Wen Liao; Wen-Lian Hsu; Hsien-Da Huang
Journal:  Nucleic Acids Res       Date:  2015-11-20       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.